Mindpeak vs Proscia (2026)
One of these scores the slide and the other manages the slides, which makes them complementary more often than competitive. Mindpeak quantifies biomarkers, with eleven European marked algorithms covering breast markers and lung immunotherapy scoring, independent published evidence and distribution through partner platforms as well as directly. Proscia is the platform, managing and analysing whole slide data for clinical laboratories and life sciences customers, with the deeper Western installed base. A laboratory trying to make its immunohistochemistry scoring reproducible across pathologists wants Mindpeak; one trying to go digital at all wants Proscia, and will then need algorithms to run on it. The variable neither publishes is the one that matters most for quantitative scoring: how the model performs on tissue prepared and scanned differently from its training set.
- Biomarker quantification across eleven European marked algorithms covering the highest volume immunohistochemistry workload, rather than cancer detection alone.
- Genuinely independent published evidence exists, and the technical claim about its breast immunohistochemistry model is specific and checkable.
- Distribution runs through partner platforms as well as direct sale, so a laboratory already running one can adopt the algorithms without a separate integration.
- The platform manages and analyses whole slide data for clinical laboratories and life sciences customers at established scale, with the deeper Western installed base.
- Serving both diagnostic work and research contracts on the same infrastructure spreads the investment across two budgets.
- For a laboratory in North America or Europe, an established platform with local support and regulatory standing is the lower risk deployment.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Mindpeak and Proscia are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Mindpeak | Proscia |
|---|---|---|
| Primary category | Digital Pathology AI | Digital Pathology AI |
| Founded | 2018 | 2014 |
| Headquarters | Hamburg, Germany | Philadelphia, Pennsylvania, United States |
| Website | mindpeak.ai | proscia.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Mindpeak its top capability grade on AI Centrality. Set against Proscia, Mindpeak grades higher on AI Centrality. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Proscia its top capability grade on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Set against Mindpeak, Proscia grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Mindpeak or Proscia?
On the axes where the AI Health Index separates them, Mindpeak grades higher on AI Centrality, and Proscia grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Proscia leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Mindpeak and Proscia differ most?
The widest separation the AI Health Index records between Mindpeak and Proscia is on Model Supply Chain Disclosure, where Mindpeak grades D and Proscia grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Mindpeak and Proscia grade the same?
The AI Health Index grades Mindpeak and Proscia the same on several axes, including Model and Technology Transparency, Clinical and Operational Evidence and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Mindpeak and Proscia not disclosed?
At the last review, at least one of Mindpeak and Proscia published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.
These sit at different layers and a laboratory may well run both, since one supplies scoring algorithms and the other supplies the platform they can run on. Mindpeak publishes no information security management certification and no health privacy position. Neither publishes pricing.
Staining and scanner variation between laboratories is the largest uncontrolled variable for quantitative immunohistochemistry in particular, because the score depends on preparation before it depends on the model, and neither vendor publishes performance across that variation.